246 related articles for article (PubMed ID: 8691473)
41. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
[TBL] [Abstract][Full Text] [Related]
42. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2005 Apr; 15(7):1877-80. PubMed ID: 15780625
[TBL] [Abstract][Full Text] [Related]
44. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
Ryzhenkov VE; Chistiakova AM; Okunevich IV
Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents.
Alagarsamy V; Solomon VR; Murugan M
Bioorg Med Chem; 2007 Jun; 15(12):4009-15. PubMed ID: 17452107
[TBL] [Abstract][Full Text] [Related]
46. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
47. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
[No Abstract] [Full Text] [Related]
48. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
[TBL] [Abstract][Full Text] [Related]
49. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
50. HPLC assay in plasma and preliminary pharmacokinetic study of a quinazolinone derivative with spasmolytic effect.
Kastner P; Klimes J; Láznícek M; Jira T
Pharmazie; 2003 Apr; 58(4):242-4. PubMed ID: 12749404
[TBL] [Abstract][Full Text] [Related]
51. Long hydrocarbon chain ether diols and ether diacids that favorably alter lipid disorders in vivo.
Mueller R; Yang J; Duan C; Pop E; Zhang LH; Huang TB; Denisenko A; Denisko OV; Oniciu DC; Bisgaier CL; Pape ME; Freiman CD; Goetz B; Cramer CT; Hopson KL; Dasseux JL
J Med Chem; 2004 Oct; 47(21):5183-97. PubMed ID: 15456261
[TBL] [Abstract][Full Text] [Related]
52. Cytochrome P450 modification by a new oxazine derivative with hypolipidemic activity.
Chrysselis MC; Rekka EA; Kourounakis PN
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):325-31. PubMed ID: 11958285
[TBL] [Abstract][Full Text] [Related]
53. Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):337-60. PubMed ID: 747093
[No Abstract] [Full Text] [Related]
54. Potential CNS active agents. II--Studies of 4(3H)-quinazolinones.
Lakhan R; Singh RL
Farmaco Sci; 1988 Sep; 43(9):745-51. PubMed ID: 3229498
[TBL] [Abstract][Full Text] [Related]
55. A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.
Hasegawa H; Muraoka M; Ohmori M; Matsui K; Kojima A
Bioorg Med Chem; 2005 Jun; 13(11):3721-35. PubMed ID: 15863001
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and antihyperlipidemic activity of novel glycosyl fructose derivatives.
Tiwari P; Puri A; Chander R; Bhatia G; Misra AK
Bioorg Med Chem Lett; 2006 Dec; 16(23):6028-33. PubMed ID: 16978864
[TBL] [Abstract][Full Text] [Related]
57. A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives.
Hasegawa H; Muraoka M; Matsui K; Kojima A
Bioorg Med Chem Lett; 2006 Feb; 16(3):727-30. PubMed ID: 16249082
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
Huang Y; Hall IH
Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
[TBL] [Abstract][Full Text] [Related]
59. Normolipemic activities of acrylophenone derivatives with antimicrotubular properties.
Bard JM; Luyckx M; Brunet C; Cazin M; Fruchart JC; Clavey V; Lesieur I; Lesieur D; Delacourte A
Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):183-7. PubMed ID: 4021650
[TBL] [Abstract][Full Text] [Related]
60. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
